Skip to content

Accelerating Cervical Cancer Elimination by Self-Sampling test

Efficacy of self-sampling for human papilloma virus test in cervical cancer screening uptake and precancer detection: a randomized control trial - ACCESS trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCT1030200276
Enrollment
20000
Registered
2020-12-25
Start date
2021-02-22
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cervical cancer

Interventions

Cervical cancer screening wtth self-sampling for HPV test

Sponsors

Hata Akira
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. Female residents of Ichihara City at the time of extraction 2. Target residents for cervical cancer screening in the fiscal year 2021 (even-numbered age) 3. Residents aged 30 years to 59 years at the point of April 1 in 2021 4. Residents who have not participated in the screening by Ichihara City for more than three years

Exclusion criteria

Exclusion criteria: 1. Residents with unknown address

Design outcomes

Primary

MeasureTime frame
Detection of cervical intraepithelial neoplasia (CIN) 2 or worse

Secondary

MeasureTime frame
Screening uptake Subjects who have received cytology test Subjects required for detaied test Subjects who have received detailed tests Detection of CIN2 or worse per one cytology test Positive predictive values Incidence of adverse events Proportion of self-sampling HPV test ordered Proportion of self-sampking HPV test ordered from the web site Proportion of self-sampling HPV test received Proportion of positive HPV test Proportion of invalid HPV test Proportion of cytology test received Time to the self-sampling HPV test ordered Time to the self-sampling HPV kit sent to the subjects Time to the self-sampling HPV kit returned from the subjects Time to HPV test ordered to the laboratory TIme to HPV test result reported from the laboratory Time to HPV test result sent to the subjects Total time Questionnaire survey Screening uptake in 2023

Contacts

Public ContactMakoto Koumi

Chiba Foundation for Health & Disease Prevention

ma-koumi@kenko-chiba.or.jp+81-43-246-8606

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026